Application
17414672 · N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease
Filed 2021-06-16 · Abandoned The official file ↗ · Art unit 1625 · Examiner Gillian A Hutter Hard · CPC C07D 213/73 · NOVARTIS AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Office actions
0
first was Restriction requirement
RCEs
0
no appeal
To first action
33.7 mo
to disposition 42.2 mo
Statutes raised
·
0 actions read